4.0
14 Sept 2024
Current employee, more than 8 years
Recommend
CEO approval
Business outlook
Pros
Work with smart, committed research and development experts. Great collaborations. Help create life-saving medicines.
Cons
New focus on quarterly earnings calls vs. long-term thinking and game-changing science. Recent influx of non-experts from "big-3" consultanting company alumni prioritizing hype over substance.